Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Get your shares .05 going going gone...last chance

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Apr 21, 2021 9:56am

199 Views

Post# 33036276

Get your shares .05 going going gone...last chance

Shorties trying real hard to keep under .05 today, good luck assoles.
Approximately 6 million shares is the bid .045 and 89000 shares to sell. LOL
Your going to get caught shorties or MM who ever is behind this. Your so fricken obvious almost criminal....

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?